Meag Munich Ergo’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-70,000
| Closed | -$526K | – | 233 |
|
2022
Q2 | $526K | Hold |
70,000
| – | – | 0.03% | 174 |
|
2022
Q1 | $665K | Hold |
70,000
| – | – | 0.05% | 156 |
|
2021
Q4 | $555K | Hold |
70,000
| – | – | 0.04% | 133 |
|
2021
Q3 | $682K | Hold |
70,000
| – | – | 0.12% | 123 |
|
2021
Q2 | $693K | Buy |
70,000
+40,000
| +133% | +$396K | 0.07% | 226 |
|
2021
Q1 | $346K | Hold |
30,000
| – | – | 0.03% | 288 |
|
2020
Q4 | $288K | Hold |
30,000
| – | – | 0.07% | 177 |
|
2020
Q3 | $270K | Hold |
30,000
| – | – | 0.05% | 187 |
|
2020
Q2 | $370K | Hold |
30,000
| – | – | 0.07% | 174 |
|
2020
Q1 | $269K | Hold |
30,000
| – | – | 0.06% | 158 |
|
2019
Q4 | $292K | Hold |
30,000
| – | – | 0.03% | 355 |
|
2019
Q3 | $207K | Sell |
30,000
-5,000
| -14% | -$34.5K | 0.01% | 516 |
|
2019
Q2 | $318K | Buy |
35,000
+30,000
| +600% | +$273K | 0.02% | 477 |
|
2019
Q1 | $78K | Sell |
5,000
-25,000
| -83% | -$390K | 0.01% | 525 |
|
2018
Q4 | $471K | Hold |
30,000
| – | – | 0.06% | 289 |
|
2018
Q3 | $634K | Hold |
30,000
| – | – | 0.04% | 336 |
|
2018
Q2 | $748K | Hold |
30,000
| – | – | 0.05% | 286 |
|
2018
Q1 | $509K | Hold |
30,000
| – | – | 0.02% | 355 |
|
2017
Q4 | $573K | Hold |
30,000
| – | – | 0.02% | 440 |
|
2017
Q3 | $516K | Hold |
30,000
| – | – | 0.02% | 252 |
|
2017
Q2 | $983K | Buy |
+30,000
| New | +$983K | 0.04% | 256 |
|
2014
Q1 | – | Sell |
-5,000
| Closed | -$200K | – | 243 |
|
2013
Q4 | $200K | Hold |
5,000
| – | – | 0.01% | 219 |
|
2013
Q3 | $189K | Hold |
5,000
| – | – | 0.01% | 214 |
|
2013
Q2 | $196K | Buy |
+5,000
| New | +$196K | 0.01% | 209 |
|